Exact Sciences Corporation's latest moves, explained simply — so you know why the numbers change.
Straight from SEC filings · updated 6 Aug 2026Shareholders received $105 cash per share; the company is now owned by Abbott and no longer trades independently.
Exact Sciences agreed to be bought by Abbott; this major deal affects the company's future and shareholder value.
Stockholders voted to accept the $105-per-share merger; approval is required before the deal closes.
Annual results show how the company performed before being acquired; investors track revenue and profits.
Quarterly and full-year earnings released; shows business performance during the year of acquisition.
Official announcement reiterates the Abbott merger terms; confirms deal is proceeding toward close.
Stocky reads Exact Sciences Corporation's official filings with the U.S. Securities and Exchange Commission (SEC) — the 8-K, 10-Q and 10-K reports every public company must file — and summarizes each one in plain English, with a link back to the original document.
Exact Sciences Corporation's most recent tracked filing was a 8-K on 23 Mar 2026: Abbott completes acquisition of Exact Sciences for $105 per share.
No. These event summaries are educational — generated from public SEC filings to help beginners understand what a company is doing. They are not buy or sell recommendations.
Educational, not financial advice. Company events summarized from public SEC filings.
Data as of 6 Aug 2026.